- Tipos de Cáncer
Tipos de Cáncer
Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.A a la Z - Tratamiento
Tratamiento del Cáncer
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
- Riesgo de concer y prevencion
- Drogas de Cáncer
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
- Lidiando
Lidiando con el Cáncer
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
- Profesionales de la salud
- Estudios Clínicos
Notas para enfermeros 
¿Cuál es mi riesgo? k? 
OncoPilot: Manejando su experiencia del cáncer 
OncoLink Cancer Blogs
Community Events Calendar 
Abramson Cancer Center 
NCI CANCERLIT® Search: Familial Adenomatous Polyposis - January 2002
National Cancer Institute®
Ultima Vez Modificado: 1 de enero del 2002
Table of Contents
1
UI - 11483640
AU - Michie S; Bobrow M; Marteau TM
TI -
Predictive genetic testing in children and adults: a study of emotional
impact.
SO - J Med Genet 2001 Aug;38(8):519-26
AD - Psychology and Genetics Research Group, Guy's, King's, and St Thomas's
Medical School, King's College London, Guy's Campus, London SE1 9RT, UK.
susan.michie@kcl.ac.uk
AIM: To determine whether, following predictive genetic testing for
familial adenomatous polyposis (FAP), children or adults receiving
positive results experience clinically significant levels of anxiety or
depression, and whether children receiving positive results experience
higher levels of anxiety or depression than adults receiving positive
results. DESIGN: Two studies, one cross sectional and one prospective.
SAMPLE: 208 unaffected subjects (148 adults and 60 children) at risk for
FAP who have undergone genetic testing since 1990. MAIN MEASURES:
Dependent variables: anxiety, depression; independent variables: test
results, demographic measures, psychological resources (optimism,
self-esteem). RESULTS: Study 1. In children receiving positive results,
mean scores for anxiety and depression were within the normal range.
There was a trend for children receiving positive results to be more
anxious and depressed than those receiving negative results. In adults,
mean scores for anxiety were within the normal range for those receiving
negative results, but were in the clinical range for those receiving
positive results, with 43% (95% CI 23-65) of the latter having scores in
this range. Regardless of test result, adults were more likely to be
clinically anxious if they were low in optimism or self-esteem. Children
receiving positive or negative results did not experience greater
anxiety or depression than adults. Study 2. For children receiving a
positive test result, mean scores for anxiety, depression, and
self-esteem were unchanged over the year following the result, while
mean anxiety scores decreased and self-esteem increased after receipt of
a negative test result over the same period of time. CONCLUSION:
Children, as a group, did not show clinically significant distress over
the first year following predictive genetic testing. Adults were more
likely to be clinically anxious if they received a positive result or
were low in optimism or self-esteem, with interacting effects. The
association between anxiety, self-esteem, and optimism suggests that
counselling should be targeted, not only at those with positive test
results, but also at those low in psychological resources.
2
UI - 11606402
AU - Heinimann K; Thompson A; Locher A; Furlanetto T; Bader E; Wolf A; Meier
TI -
R; Walter K; Bauerfeind P; Marra G; Muller H; Foernzler D; Dobbie Z
Nontruncating APC germ-line mutations and mismatch repair deficiency
play a minor role in APC mutation-negative polyposis.
SO - Cancer Res 2001 Oct 15;61(20):7616-22
AD - Research Group Human Genetics, Division of Medical Genetics, University
Clinics, 4031 Basel, Switzerland. karl.heinimann@unibas.ch
Familial adenomatous polyposis, an autosomal-dominantly inherited
colorectal cancer predisposition syndrome, is caused by germ-line
mutations in the adenomatous polyposis coli (APC) gene. Despite the use
of different screening methods, studies worldwide fail to identify APC
mutations in 20-50% of all familial adenomatous polyposis patients (APC
mutation-negatives). In this study, missense mutations in the coding
region of the APC gene, which would have been missed by the protein
truncation test, as well as mutations in the APC promoter and the 3'
untranslated region, were determined by the single nucleotide
polymorphism discovery assay and direct DNA sequencing in 31
mutation-negative polyposis patients. Seventeen gene alterations were
identified, whereof four (12.9%) represent possibly pathogenic germ-line
mutations: silent A290T (promoter) and A8822G (3' untranslated region)
as well as missense R99W and E1317Q (coding region). The 27 remaining,
truly APC mutation-negative polyposis patients displayed a significantly
later age at diagnosis compared with APC mutation carriers (46.1 versus
35.2 years; P < 0.01). APC mutation-negative individuals with >100
colonic polyps were more likely to present with extracolonic disease (P
< 0.05) than those with <100. Assessment of microsatellite instability
(MSI), a hallmark of mismatch repair deficiency, in 68 tumors from 21
truly APC mutation-negative patients, identified 4 (5.9%) unstable
tubulo-villous adenomas (3 MSI-High and 1 MSI-Low), stemming from 4
(19%) unrelated individuals and likely to be caused by hMLH1 promoter
hypermethylation. In conclusion, only a small proportion of APC
germ-line mutation carriers is missed by the protein truncation test,
and mismatch repair deficiency does not seem to substantially contribute
to tumor development in APC mutation-negative polyposis patients.
3
UI - 11600806
AU - Pistorius S; Schackert HK; Saeger HD
TI -
[Hereditary colorectal carcinomas - reflection on preventive surgery]
SO - Onkologie 2001 Sep;24 Suppl 5():4-8
AD - Klinik und Poliklinik fur Viszeral, Thorax und Gefasschirurgie,
Universitatsklinikum Carl Gustav Carus, TU Dresden, Germany.
spisto2522@aol.com
Nonpolyposis Colorectal Cancer (HNPCC) accounts for about 5% of all
colorectal cancers and is the most frequent familial form; familial
adenomatous polyposis coli accounts for about 1%. Prerequisitive for
individually tailored surveillance is the identification of the
pathogenic germline mutation. In classical FAP, surgical standard is a
restorative proctocolectomy while in HNPCC there is no surgical standard
other than standard oncological resection due to missing evidence. In
HNPCC, prophylactic colectomy before the onset of the first colorectal
cancer is not recommended. Main arguments for the extension of the
resection in the case of the first colorectal carcinoma in HNPCC are the
rate of metachronous colorectal carcinomas of 40-45% in a 10-year
interval and rapid tumor progression. In HNPCC, in the case of first
colon cancer a subtotal colectomy seems to be indicated. A
proctocolectomy or, if indicated, a restorative proctocolectomy may be
considered in the case of carcinomas in the lower rectum. These
considerations should be evaluated in a prospective clinical trial.
Counselling, molecular diagnosis and surgery in patients with hereditary
colorectal cancers should only be performed in interdisciplinary
centers. Copyright 2001 S. Karger GmbH, Freiburg
4
UI - 11680173
AU - Abramowicz M
TI -
[Genetic aspects of colorectal cancer]
SO - Rev Med Brux 2001 Sep;22(4):A199-202
AD - Service de Genetique Medicale, Centre de Genetique, Laboratoire de
Genetique Medicale, Hopital Erasme, U.L.B.
Cancer is a hereditary disease at the level of an individual cell and
its daughter cells. The tumor genotype causing the tumor phenotype is
now quite well known in colorectal cancer and allows, among others, to
perform pathology examination at the molecular level. A distinct topic
addresses individual predisposition to colorectal cancer. Its molecular
nature is well know in the relatively rare cases, about 5-10% of
colorectal cancers, where such a predisposition is major, and is
transmitted in families of affected subjects following a hereditary,
mendelian mode of inheritance. Specifically, two types of hereditary
adenomatous tumors, polyposis and hereditary nonpolyposis colorectal
cancer, may benefit from genetic analysis in order to target cancer
prevention. New genetic tests will probably develop in the coming years,
allowing for the analysis of more modest, and less clearly hereditary
individual risks.
5
UI - 11680042
AU - Tejpar S; Cassiman JJ; Van Cutsem E
TI -
The molecular basis of colorectal cancer.
SO - Acta Gastroenterol Belg 2001 Jul-Sep;64(3):249-54
AD - Center for Human Genetics, University of Leuven, Herestraat 49, 3000
Leuven, Belgium. Sabine.tejpar@med.kuleuven.ac.be
Colorectal cancers, whether sporadic or hereditary, are caused by a
defined set of molecular events. The genes and pathways involved in the
earliest steps of tumorigenesis have crucial functions in the regulation
of normal crypt homeostasis. Further insight into these pathways can
lead to the development of useful prognostic indicators, and target
preventive and therapeutic strategies in the management of colorectal
cancer. Mutations in the APC/beta-catenin/Tcf-4 pathway lead to
important changes in stem cell dynamics, before clinically identifiable
lesions appear. Preventive strategies aimed at reversing these changes
or therapeutic interventions targeting cell populations with these
alterations should be most efficacious.
6
UI - 11693343
AU - Raedle J; Friedl W; Engels H; Koenig R; Trojan J; Zeuzem S
TI -
A de novo deletion of chromosome 5q causing familial adenomatous
polyposis, dysmorphic features, and mild mental retardation.
SO - Am J Gastroenterol 2001 Oct;96(10):3016-20
AD - 2nd Department of Internal Medicine and Institute of Human Genetics,
University of Frankfurt/Main, Frankfurt am Main, Germany.
Familial adenomatous polyposis (FAP) is an autosomal dominant disorder
that typically presents with colorectal cancer secondary to extensive
adenomatous polyps of the colon. The molecular basis and clinical
phenotype of FAP are well known. Recurrent episodes of severe abdominal
pain and a positive fecal occult blood test in an 18-yr-old boy with
mild mental retardation and slight dysmorphic features of the face,
head, and skeletal system led to the diagnosis of FAP. The clinical
workup revealed the presence of over 100 sessile colonic polyps but no
polyp formation in the upper GI tract, no cancer development, nor other
FAP-associated lesions. To find out whether there is an association
between mental retardation and FAP we performed a chromosome analysis
including comparative genomic hybridization and an indirect genotype
analysis with polymorphic markers from the APC gene region. Cytogenetic
analysis showed an interstitial deletion of chromosomal region 5q that
was confined to the region 5q21-q22 by comparative genomic
hybridization. The deletion, spanning about 10 centimorgans, encompassed
the complete APC gene and can be considered as causative for FAP.
Moreover, molecular genetic analysis with polymorphic markers flanking
the APC gene demonstrated a de novo deletion on the paternal chromosome.
Cytogenetically detectable deletions on chromosome 5 including the APC
gene generally lead to an associated gene deletion syndrome. Individuals
who present with mild mental retardation and dysmorphic features should
therefore be investigated for chromosomal deletions. If the deletion
encompasses the APC gene, these patients are at high risk of developing
FAP and associated complications.
7
UI - 11691707
AU - Murakami Y; Gondo N; Okamura H; Akechi T; Uchitomi Y
TI -
Guilt from negative genetic test findings.
SO - Am J Psychiatry 2001 Nov;158(11):1929
8
UI - 11713930
AU - Lynch HT; Thorson AG; McComb RD; Franklin BA; Tinley ST; Lynch JF
TI -
Familial adenomatous polyposis and extracolonic cancer.
SO - Dig Dis Sci 2001 Nov;46(11):2325-32
AD - Department of Preventive Medicine, Creighton University School of
Medicine Omaha, Nebraska 68178, USA.
Our purpose is to focus attention on the cancer family history, coupled
with an understanding of the natural history and extracolonic tumor
spectrum of familial adenomatous polyposis (FAP), through a family
study. This family report provides an example of how colorectal cancer
(CRC) can be prevented by knowledgeable gastroenterologists and
colorectal surgeons who educate and compassionately counsel members of
high-risk families so that their compliance with diagnostic screening
and, ultimately, with protection through prophylactic colectomy, is
achieved. A working pedigree of this extended family was constructed
through interviews with the proband, followed by questionnaires sent to
all primary and secondary relatives. Appropriately signed permission
forms enabled us to secure pertinent medical and pathology records in
order to ensure accuracy of historical information. Integral
extracolonic tumors included medulloblastoma, papillary thyroid
carcinoma, hepatoblastoma, and desmoid tumors. We conclude that, due in
part to improved longevity as a result of being spared CRC, several
family members have developed certain FAP integral extracolonic cancers.
9
UI - 11711728
AU - Wallace MH; Forbes A; Beveridge IG; Spigelman AD; Hewer A; Venitt S;
TI -
Phillips RK
Randomized, placebo-controlled trial of gastric acid-lowering therapy on
duodenal polyposis and relative adduct labeling in familial adenomatous
polyposis.
SO - Dis Colon Rectum 2001 Nov;44(11):1585-9
AD - ICRF Colorectal Cancer Unit and The Polyposis Registry and the Academic
Institute, St. Mark's Hospital, Northwick Park, Harrow, United Kingdom.
PURPOSE: Bile has been implicated in the pathogenesis of duodenal polyps
in patients with familial adenomatous polyposis. In vitro experiments
have shown that familial adenomatous polyposis bile is capable of
producing DNA adducts. This effect can be ameliorated by increasing the
pH of the incubate. The aim of this double-blind randomized
placebo-controlled trial was to examine the effect of oral ranitidine on
duodenal polyposis in a group of patients with familial adenomatous
polyposis. METHODS: Twenty-six patients with familial adenomatous
polyposis were randomly assigned to ranitidine 300 mg daily or placebo
for six months after baseline endoscopy. Polyp counts were performed and
biopsy specimens taken to detect DNA adducts by 32P-postlabeling.
RESULTS: No difference was seen in polyp numbers (P = 0.9) or relative
adduct labeling (P = 0.7) after treatment with ranitidine or placebo.
DISCUSSION: Acid suppression therapy does not seem to improve duodenal
polyposis despite in vitro findings. On the other hand, ranitidine does
not exacerbate actual (or markers of) neoplasia in this highly
tumor-prone condition.
10
UI - 11711730
AU - Ponz de Leon M; Varesco L; Benatti P; Sassatelli R; Izzo P; Scarano MI;
TI -
Rossi GB; Di Gregorio C; Gismondi V; Percesepe A; de Rosa M; Roncucci L
Phenotype-genotype correlations in an extended family with adenomatosis
coli and an unusual APC gene mutation.
SO - Dis Colon Rectum 2001 Nov;44(11):1597-604
AD - Dipartimento di Medicina Interna, Universita di Modena, Modena, Italy.
PURPOSE: Genotype-phenotype correlations in familial adenomatous
polyposis are only partially understood and, in particular, little is
known about the biomolecular characteristics of desmoid tumors, which
are one of the most serious and frequent manifestations of familial
adenomatous polyposis. In the present study, we describe a family with
familial adenomatous polyposis, with peculiar clinical characteristics
(i.e., frequency and severity of desmoid neoplasms) associated with an
unusual mutation of the adenomatosis polyposis coli gene. If confirmed
by other investigations, these findings might help to understand the
biologic mechanisms by which specific adenomatosis polyposis coli
mutations predispose to desmoid tumors. METHODS: The family with
familial adenomatous polyposis, living in southern Italy, was studied
from 1985 to the end of 1999; at this date, 15 individuals have been
affected by histologically verified familial adenomatous polyposis, 11
of whom had desmoid tumors. A total of 19 family members were studied
for adenomatosis polyposis coli gene mutations; 13 of them tested
positive and 6 negative. The analytical procedure-previously
described-consisted of the extraction of peripheral blood cell DNA,
amplification of exon 15 by polymerase chain reaction, single-strand
conformation polymorphism analysis, and direct sequencing of the DNA
fragment containing the mutation. RESULTS: The main clinical features of
the family were 1) a high frequency of desmoid tumors and, consequently,
a high penetrance of the desmoid trait in all branches of the family and
in 11 (73.3 percent) of 15 affected individuals and 2) severity of
desmoids in at least 4 family members, 2 of whom died for causes related
to the presence of these tumors. The molecular basis of the disease was
an uncommon mutation of the adenomatosis polyposis coli gene, consisting
of a large deletion of 310 base pairs at codon 1,464, with duplication
of the breakpoint (4,394ins15del310), leading to a stop codon at
position 1,575. CONCLUSIONS: The present study shows that a truncating
mutation in the adenomatosis polyposis coli gene at the beginning of the
region frequently associated with desmoids induced a familial
adenomatous polyposis phenotype featured by a high penetrance of the
desmoid trait, with severe disease in several affected members of both
sexes. The study may help to understand the biologic mechanisms of
genotype-phenotype correlations in adenomatosis coli.
11
UI - 9321987
AU - Hughes-Fulford M; Boman B
TI -
Growth regulation of Gardner's syndrome colorectal cancer cells by
NSAIDs.
SO - Adv Exp Med Biol 1997;407():433-41
AD - Department of Medicine, Veterans Affairs Medical Center, San Francisco,
CA, USA.
12
UI - 11685545
AU - Takafuji V; Lublin D; Lynch K; Roche JK
TI -
Mucosal prostanoid receptors and synthesis in familial adenomatous
polyposis.
SO - Histochem Cell Biol 2001 Aug;116(2):171-81
AD - Department of Internal Medicine, Box 801317, MR-4 Building, University
of Virginia Health System, Charlottesville, VA 22908, USA.
Chronic ingestion of non-steroidal anti-inflammatory medication is
reported to delay or, in part, reverse development of polyps in the
colon, but the mechanism for this effect is unknown. Using mRNA and
immunoglobulin probes, specific for prostanoid receptors and for
prostaglandin endoperoxide synthase (COX 1 and 2), we sought to define,
by in situ and in vitro techniques, changes in PGE2 receptors and
synthesis in cell populations of precancerous familial adenomatous
polyposis (FAP) colonic mucosa. In FAP, expression of prostanoid
receptors EP3 and EP4 among colonic lamina propria mononuclear and
lateral crypt epithelial cells was robust, with 53.9+/-5.3% of
mononuclear cells staining EP4+. When sections of normal colonic mucosa
were examined by similar techniques, prostanoid receptor EP4 was
expressed on only 21.3+/-1.2% of lamina propria mononuclear cells
(including CD4+ T lymphocytes), as well as on surface and lateral crypt
epithelium, and this distribution was found at the mRNA level as well.
When receptor expression was quantitated by densitometry, immunoreactive
EP3 protein on deep basolateral (but not other) FAP crypt epithelium was
enhanced 2.8-fold over normal, and the number of prostanoid receptor
EP4+ mononuclear cells by 2.5-fold. On the other hand, while COX 1
expression in mononuclear cells was prominent in normal and FAP mucosa,
densitometric analysis showed immunoreactive prostaglandin endoperoxide
synthase levels were further increased in FAP, due to a greater than
fourfold elevation of COX 2 expression among mononuclear cells and
epithelia. Our data suggest enhanced cell-specific prostanoid receptor
expression and increased prostanoid synthesis in precancerous FAP
mucosa.
13
UI - 10980114
AU - Abraham SC; Nobukawa B; Giardiello FM; Hamilton SR; Wu TT
TI -
Fundic gland polyps in familial adenomatous polyposis: neoplasms with
frequent somatic adenomatous polyposis coli gene alterations.
SO - Am J Pathol 2000 Sep;157(3):747-54
AD - Department of Pathology, The Johns Hopkins University School of
Medicine, Baltimore, Maryland 21205-2196, USA.
Fundic gland polyps (FGPs) are the most common gastric polyps in
patients with familial adenomatous polyposis (FAP). FGPs have
traditionally been regarded as nonneoplastic, possibly hamartomatous
lesions, but the pathogenesis of FGPs in both FAP and sporadic patients
remains unclear. FGPs in FAP can show foveolar dysplasia, and rarely
invasive gastric adenocarcinoma has been reported in patients with FAP
and fundic gland polyposis. Using direct gene sequencing and allelic
loss assays at 5q, we analyzed somatic adenomatous polyposis coli (APC)
gene alterations in 41 FAP-associated FGPs (20 with foveolar dysplasia,
six indefinite for dysplasia, and 15 nondysplastic) and 13 sporadic
FGPs. The foveolar epithelium and dilated fundic glands of the polyps
were separately microdissected and analyzed in 25 of 41 FAP-associated
FGPs and 13 of 13 sporadic FGPs. Somatic APC gene alterations were
identified frequently (21 of 41 cases, 51%) in FAP-associated FGPs. Both
the foveolar epithelium and the dilated fundic gland epithelium
comprising the FGPs were shown to carry the same somatic APC gene
alteration in 24 (96%) of 25 cases. Furthermore, there was no difference
in the frequency of somatic APC gene alterations between FGPs with
foveolar dysplasia (10 of 20, 50%), indefinite for dysplasia (four of
six, 67%), and nondysplastic (seven of 15, 47%) in FAP patients (P: =
0.697). In contrast, FGPs from non-FAP patients showed infrequent (one
of 13, 8%) APC gene alterations (P: = 0.008). These results show that
FGPs in FAP patients are pathogenetically distinct from sporadic FGPs.
Somatic, second-hit APC gene alterations, which precede morphological
dysplasia in many FAP-associated FGPs, indicate that FGPs arising in the
setting of FAP are neoplastic lesions.
14
UI - 11731419
AU - Boman BM; Fields JZ; Bonham-Carter O; Runquist OA
TI -
Computer modeling implicates stem cell overproduction in colon cancer
initiation.
SO - Cancer Res 2001 Dec 1;61(23):8408-11
AD - Division of Genetic and Preventive Medicine, Thomas Jefferson
University, Philadelphia, Pennsylvania 19107, USA.
Bruce.Boman@mail.tju.edu
On the basis of our investigation of the premalignant crypt phenotype in
familial adenomatous polyposis patients, the hypothesis is developed
that tumor initiation in the colon is caused by crypt stem cell
overproduction. A novel kinetic model for the colonic crypt was used to
investigate how the earliest tissue abnormality (altered crypt labeling
index) arises in these patients who have a mutant APC genotype. Only an
increase in crypt stem cell number, not changes in the rate of cell
cycle proliferation, differentiation, or apoptosis of the non-stem cell
population, simulated this abnormality. This suggests that APC regulates
the number of stem cells in the colonic crypt and when the cells become
mutant, an expansion of the crypt stem cell population results.
15
UI - 11605029
AU - Strippoli P; Sarchielli S; Santucci R; Bagnara GP; Brandi G; Biasco G
TI -
Cold single-strand conformation polymorphism analysis: optimization for
detection of APC gene mutations in patients with familial adenomatous
polyposis.
SO - Int J Mol Med 2001 Nov;8(5):567-72
AD - Institute of Histology and Embryology, University of Bologna, I-40138
Bologna, Italy.
Over 200 adenomatous polyposis coli (APC) gene mutations have been
described in familial adenomatous polyposis (FAP) patients. Recent
single-strand conformation polymorphism (SSCP) screening methods have
introduced minigel runs, simple ethidium bromide staining and external
temperature control without any loss of sensitivity (cold-SSCP). In
order to test the effectiveness in APC mutation detection, cold-SSCP was
employed following polymerase chain reaction (PCR) amplification in
three patients with FAP. Different running parameter combinations were
compared. The three mutations already known were all diagnosed by
cold-SSCP. The gel concentration was found to be essential in detecting
the single-base substitution in fragments of different lengths. The
observation of deletions was not affected by gel concentrations and
heteroduplex bands were always produced. The temperature or glycerol
addition did not significantly affect sensitivity. This modified
cold-SSCP method provides a simple and effective way for detecting
several known Apc gene mutations without any loss of sensitivity and
could be useful for large-scale molecular diagnosis of FAP.
16
UI - 11741105
AU - Pang CP; Fan DS; Keung JW; Baum L; Tang NL; Lau JW; Lam DS
TI -
Congenital hypertrophy of the retinal pigment epithelium and APC
mutations in Chinese with familial adenomatous polyposis.
SO - Ophthalmologica 2001 Nov-Dec;215(6):408-11
AD - Department of Ophthalmology and Visual Sciences, The Chinese University
of Hong Kong, China. cppang@cuhk.edu.hk
Mutations in the adenomatous polyposis coli gene (APC) often cause both
congenital hypertrophy of the retinal pigment epithelium (CHRPE) and
familial adenomatous polyposis (FAP). To investigate the relationship
between APC mutations, CHRPE and FAP, all FAP patients at the Prince of
Wales Hospital, Hong Kong, were asked to participate in a study. Ten
Chinese patients from 6 kindreds and their family members volunteered,
along with 12 healthy control subjects selected among hospital visitors
and staff. All were examined for dilated fundus by indirect
ophthalmoscopy. Mutations in APC coding exons were detected by
sequencing. In one FAP patient, a novel A insertion at codon 1023 was
detected. Three previously reported mutations were detected in 6 FAP
patients: a deletion of ACAAA at codon 1061, and 2 truncating point
substitutions at codons 216 and 283. In 3 FAP patients, no APC mutation
was found, suggesting that mutations in APC coding regions are not the
sole cause of FAP or CHRPE. A total of 64 CHRPE lesions were found in
FAP patients and some relatives with and without APC mutations. Contrary
to most reports, APC mutations before exon 9 did cause CHRPE lesions,
albeit relatively few. Copyright 2001 S. Karger AG, Basel
17
UI - 1646139
AU - Olschwang S; Weiffenbach B; Laurent-Puig P; Melot T; Vassal A; Falls K;
TI -
Salmon RJ; Parc R; Strong L; Nakamura Y; et al
Genetic characterization of the APC locus involved in familial
adenomatous polyposis.
SO - Gastroenterology 1991 Jul;101(1):154-60
AD - Laboratory of Tumor Genetics, Institut Curie, Paris, France.
Familial adenomatous polyposis is a rare disease inherited in a
Mendelian dominant fashion. It is characterized by the occurrence of
more than 100 adenomatous polyps in the large bowels of affected
individuals. The genetic defect responsible for adenomatous polyposis
resides at a locus called APC which has been localized to the long arm
of human chromosome 5. In this study, the APC locus was mapped with
respect to 11 markers known to map to this chromosomal segment. Linkage
of APC to four of these markers had been previously reported. Three
additional markers are shown here to be linked to APC. By multipoint
analysis, the APC locus maps to an interval bounded by D5S49 and D5S58.
The refined map of the APC locus and the new markers described here
improve the informativeness and accuracy of the presymptomatic diagnosis
of familial adenomatous polyposis.
18
UI - 1650309
AU - Moslein G; Kadmon M
TI -
[Family screening in familial adenomatous polyposis--organization of a
preventive and after care program for patients and risk probands]
SO - Chirurg 1991 Apr;62(4):357-9
19
UI - 1657548
AU - Neumann S
TI -
[Cowden syndrome with an ovarian tumor (multiple hamartoma syndrome]
SO - Chirurg 1991 Aug;62(8):629-30
AD - Chirurgische Abteilung, Kreiskrankenhaus Sulingen.
20
UI - 1664100
AU - Laurent-Puig P; Olschwang S
TI -
[Genetic transmission of colorectal adenomas]
SO - Presse Med 1991 Dec 14;20(43):2183-4
21
UI - 1311383
AU - Armitage NC
TI -
Familial adenomatous polyposis.
SO - J R Soc Med 1992 Feb;85(2):63-5
22
UI - 1315892
AU - Huismans H
TI -
[Familial adenomatous polyposis from the ophthalmologic viewpoint]
SO - Klin Monatsbl Augenheilkd 1992 Mar;200(3):213-8
Familial adenomatous polyposis is dominant autosomal heritable and
pre-cancerous. Characteristic changes of ocular fundus, multiple and
bilateral retinal dysplasias, permit diagnosis in presymptomatic stage,
significant especially not at least for sporadic cases of polyposis
recti and coli, which are 40 per-cent of all. Contrary to often
wellknown risk-families this group can't be realized epidemiologically,
but complications are the same.
23
UI - 1316297
AU - Boman BM
TI -
Molecular genetic markers in familial adenomatous polyposis.
SO - Gastroenterol Clin Biol 1992;16(3):203-4
24
UI - 1316298
AU - Olschwang S; Laurent-Puig P; Melot T; Thuille B; Vassal A; Parc R;
TI -
Salmon R; Thomas G
[Familial adenomatous polyposis: early diagnosis by genetic mapping]
SO - Gastroenterol Clin Biol 1992;16(3):205-9
AD - Laboratoire de Genetique des Tumeurs, Institut Curie, Paris.
The use of probes detecting polymorphic loci within the human population
has enabled accurate localization of the genetic defect responsible for
familial adenomatous polyposis on chromosome 5. This was used to screen
two families for the presymptomatic diagnosis in children of an affected
parent. In both cases, the use of 8 polymorphic probes located on either
side of the gene provided information which could be used in the
management of children born from the patients at risk. The set of probes
used in this work should be informative in most of the affected
adenomatous polyposis families.
25
UI - 1327363
AU - Macpherson AJ; Bjarnason I; Forgacs IC
TI -
Discovery of the gene for familial adenomatous polyposis.
SO - BMJ 1992 Apr 4;304(6831):858-9
26
UI - 1330993
AU - Calmes JM; Rutz HP; Suardet L; Givel JC
TI -
[Hereditary colorectal cancer: observations of a family study]
SO - Helv Chir Acta 1992 Aug;59(2):349-54
AD - Service de chirurgie generale, CHUV, Lausanne.
Described in Switzerland in the early '60, the major features of
hereditary non-polyposis colon cancer syndrome (HNPCCS) were established
20 years ago by H. T. Lynch. HNPCCS accounts for at least 60% of the
colon cancer etiology. Cancer family syndrome is defined by the presence
of extracolonic primary tumors in addition to colon cancer. Both
syndromes are transmitted by an autosomic dominant pattern. None of the
known biomarkers are specific and/or sensitive enough to rely on their
predictive values of patient's risks. A typical Swiss family was
investigated on the basis of the cancer-prone family history. 21% of the
family members observed over 5 generations presented one or more (30% of
the cases) colo-rectal neoplasms at the age of 50. 55% of the tumors
were right sided. Histologically, half of the tumors were mucinous. 30%
of metachronous cancer appeared within 10 years. Polyps (1-3) and flat
adenomas were associated to the lesion in 57%. Extra-colonic tumors
appeared in 18% of family members and in half of the colon cancer
patients. The sites of these tumors were the urinary tract, ovary, small
bowel, breast and stomach. Two fibroblast strains of affected
individuals were established. No increased tetraploidy was noted.
Preliminary results suggest that this two strains are rather sensitive
to ionising radiation. Often neglected, family history of colon cancer
remains the major diagnostic and decision-making tool of a such
syndrome. It will necessitate special treatment of affected subjects and
early screening of the relatives.(ABSTRACT TRUNCATED AT 250 WORDS)
27
UI - 1333171
AU - Koorey DJ; Smith A
TI -
Normal high-resolution karyotypes in 26 unrelated individuals with
hereditary colorectal neoplasia.
SO - Am J Gastroenterol 1992 Dec;87(12):1736-9
AD - A.W. Morrow Gastroenterology and Liver Centre, Royal Prince Alfred
Hospital, Sydney, Australia.
High-resolution karyotype analysis was performed on peripheral blood
cultures from 26 patients with hereditary colorectal neoplasia. The aims
of this study were: first, to determine the frequency of cytogenetically
visible chromosome 5q deletions in familial adenomatous polyposis and,
thus, whether routine karyotype analysis should be included in screening
regimens for affected families; and, second, to search for chromosomal
abnormalities in hereditary nonpolyposis colorectal cancer that might
assist in localizing the gene or genes responsible. No cytogenetic
abnormalities were detected among 21 unrelated patients with familial
adenomatous polyposis and five with hereditary nonpolyposis colorectal
cancer. We conclude that cytogenetic analysis is of no value in the
management of families with typical familial adenomatous polyposis or
Gardner's syndrome, and should be confined to those families with
atypical features such as mental retardation or facial dysmorphism.
28
UI - 8402712
AU - Varesco L; Gismondi V; James R; De Benedetti L; Heouaine A; Biticchi R;
TI -
Masetti E; Bertario L; Sala P; Grammatico P; et al
APC gene mutations in Italian familial polyposis coli patients.
SO - Cancer Detect Prev 1993;17(2):279-81
AD - Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.
Adenomatous polyposis coli is an autosomal dominant disease
characterized by the development of hundreds of colorectal adenomas in
young adults. If prophylactic colectomy is not performed, colorectal
cancer develops in virtually all affected individuals by the fifth
decade of life. All at-risk relatives older than 10 years of age need to
be screened regularly by endoscopy. Recently, the gene responsible for
the disease, the APC gene, was cloned. The finding of inactivating
mutations of the APC gene in Italian APC patients allowed us to offer
DNA-based diagnostic tests to these families.
29
UI - 2887069
AU - Lisnianskii IE; Gar'kavtseva RF; Zaletaev DV; Kuz'minov AM
TI -
[Hereditary multiple endocrine neoplasm syndromes]
SO - Vopr Onkol 1987;33(6):57-61
Three syndromes of multiple endocrine neoplasia (MEN) have been
identified to date: MEN--I, IIa and IIb. They involve various
combinations of endocrine neoplasia and occur mostly in young patients.
Predisposition transmission mechanism is autosomal-dominant with total
penetration and variable expressiveness. Patients' families should
undergo screening which involves identification of biochemical markers
and cytogenetic examination. This would allow identification of subjects
at high risk for cancer and improvement of early diagnosis.
30
UI - 2539335
AU - Paraskeva C; Harvey A; Finerty S; Powell S
TI -
Possible involvement of chromosome 1 in in vitro immortalization:
evidence from progression of a human adenoma-derived cell line in vitro.
SO - Int J Cancer 1989 Apr 15;43(4):743-6
AD - Department of Pathology, University of Bristol Medical School, UK.
We have previously reported that continuous in vitro passage in the
presence of 3T3 feeders of a non-tumorigenic adenoma-derived epithelial
cell line, designated PC/AA, resulted in its becoming immortal. At early
passage PC/AA was normal diploid, whereas every cell of PC/AA late
passage had an isochromosome 1(q) which led us to suggest that
abnormalities of chromosome 1 may be involved in tumour progression. We
now report the isolation of a 3T3-feeder-independent variant of
early-passage PC/AA, designated PC/AA/FI, which was immortal in vitro
and remained non-tumorigenic. Each cell of PC/AA/FI again has an
isochromosome 1(q), like the late-passage PC/AA. However, with PC/AA/FI
it is the other chromosome 1 of the homologous pair which is involved in
the formation of the isochromosome 1(q). This is possible to determine
because of the polymorphic centromeric heterochromatin on chromosome 1
of the early-passage PC/AA. With the late-passage PC/AA (grown with 3T3
feeders) the homologue with the large C-band has given rise to an
isochromosome 1(q) whereas with PC/AA/FI it is the other homologue with
the smaller C-band which has given rise to this isochromosome. Both the
immortal PC/AA/FI and the immortal PC/AA late passage, therefore, have
independent abnormalities involving chromosome 1. These results indicate
that chromosome 1 may be involved in in vitro immortalization.
31
UI - 2558344
AU - Dutrillaux B
TI -
[Genetic factors in colorectal cancer]
SO - Pathol Biol (Paris) 1989 Nov;37(9):981-2
AD - Institut Curie, Section de Biologie, Paris, France.
32
UI - 2843422
AU - Bazhenova MD; Al'tshuler BA
TI -
[Assessment of the risk of recurrence isolated cases of dominantly
inherited diseases with incomplete penetrance and age-related
dependence]
SO - Genetika 1988 May;24(5):947-50
A modification of the method for risk estimation in isolated cases of
autosomal dominant disorders with reduced penetrance is presented. It is
based on the Bayesian theorem and considers such parameters as fitness,
age-specific expressivity of the gene and the effect of parental age on
mutation rate. The definite expression of the risk estimation is
proposed. Using hereditary polyposis as an example, possible risks are
proposed. The table of risks, depending on the parental age, is given.
33
UI - 8071957
AU - Barber JC; Ellis KH; Bowles LV; Delhanty JD; Ede RF; Male BM; Eccles DM
TI -
Adenomatous polyposis coli and a cytogenetic deletion of chromosome 5
resulting from a maternal intrachromosomal insertion.
SO - J Med Genet 1994 Apr;31(4):312-6
AD - Wessex Regional Genetics Laboratory, Salisbury District Hospital,
Odstock, UK.
We present the clinical and laboratory findings in an institutionalised
adult patient originally referred for autism. A high risk of colorectal
cancer was predicted when an interstitial deletion of the long arm of
chromosome 5, del(5)(q15q22.3), was detected in her lymphocytes and
deletion of the MCC and APC genes confirmed by molecular analysis.
Adenomatous polyposis coli and carcinoma of the rectum were subsequently
diagnosed in the patient. She was profoundly mentally retarded,
autistic, and had minor dysmorphic features consistent with those of
previous patients with similar deletions. The deletion arose as a result
of recombination within the small insertion loop formed at meiosis by
the direct insertion (dir ins(5)(q22.3q14.2q15)) found in the patient's
mother. This family further confirms the cytogenetic mapping of both MCC
and APC genes to 5q22 and comparison with other recent cases suggests
that both genes and their closely linked markers lie within the 5q22.1
subband.
34
UI - 7706067
AU - Hartig C; Stieler W; Stadler R
TI -
[Muir-Torre syndrome. Diagnostic criteria and review of the literature]
SO - Hautarzt 1995 Feb;46(2):107-13
AD - Hautklinik, Minden.
We report on a 63-year-old female patient with Muir-Torre syndrome
(MTS). In the course of this disease two carcinomas of the colon, a
kerato-acanthoma and multiple sebaceous gland tumours, including four
sebaceous carcinomas, appeared. This case is thought to be a hereditary
form as one of daughters was also found to have a sebaceous epithelioma.
MTS is a mostly autosomal-dominant disease with the association of
sebaceous gland tumours and internal carcinomas. As the malignant
tumours only show slight aggressiveness the prognosis is quite
favourable. Oral isotretinoin therapy was successfully used for the
inhibition of sebaceous gland proliferation. A narrower definition is
presented and an updated survey of the published cases is given.
Furthermore, the histopathologic peculiarities of sebaceous gland
tumours, especially of sebaceous gland carcinomas, are discussed and
compared to sebaceous gland tumours not connected with MTS. A total
number of 100 of the 135 published cases of MTS were included and
analysed regarding sebaceous gland tumours and other skin tumours. The
data on internal carcinomas were taken from the work of Cohen et al.
(1991) and 11 current cases were added.
35
UI - 8763122
AU - Pocard M; Salmon RJ
TI -
[Genetics of colorectal cancers]
SO - Ann Chir 1996;50(3):211-6
36
UI - 8859104
AU - Kilmartin DJ; Mooney DJ; Acheson RW; Payne SJ; Maher ER; Eustace P
TI -
von Hippel-Lindau disease and familial polyposis coli in the same
family.
SO - Arch Ophthalmol 1996 Oct;114(10):1294
AD - Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin 2,
Ireland.
37
UI - 9010867
AU - Traboulsi EI; Apostolides J; Giardiello FM; Krush AJ; Booker SV;
TI -
Hamilton SR; Hussels IE
Pigmented ocular fundus lesions and APC mutations in familial
adenomatous polyposis.
SO - Ophthalmic Genet 1996 Dec;17(4):167-74
AD - Johns Hopkins Center for Hereditary Eye Diseases, Wilmer
Ophthalmological Institute, Baltimore, MD, USA.
BACKGROUND: Familial adenomatous polyposis (FAP) results from a germline
mutation in the adenomatous polyposis coli (APC) gene on chromosome
5q21. The extracolonic manifestations of FAP include pigmented ocular
fundus lesions (POFLS), cutaneous cysts, osteomas, occult radio-opaque
jaw lesions, odontomas, desmoids, and extracolonic cancers. POFLS are
present at birth in about 80% of patients with FAP and are excellent
clinical congenital markers for the disease. We studied the distribution
of POFLS by number and APC mutation in families of the Johns Hopkins
Polyposis Registry. MATERIALS AND METHODS: Of the 51 families with FAP,
42 (82%) had an identifiable APC mutation. We correlated the
presence/absence and distribution by number of POFLS with the type and
location of the mutation in the APC gene in 21 families where an ocular
examination had been performed in at least one affected member, and
where a systematic search for mutations in the APC gene had been
undertaken. Families were considered POFL-positive if the average number
of lesions per patient was three or more, or if at least one family
member had three or more lesions. RESULTS: Fifteen of the 21 families
(71.4%) were POFL-positive. Mutations of the APC gene were detected in
15 of the 21 families. Of these, 12 (80%) were POFL-positive. Families
with mutations at condons 215 (exon 5) and 302 (exon 8) were
POFL-negative. Families with mutations at condons 541, 625, 1055, 1059,
1061, 1230, 1309, 1465, and 1546 (exons 12-15) were POFL-positive. One
patient with a mutation at codon 2621 (exon 15) had no POFLS.
CONCLUSIONS: Mutations in exons 1-8 and the distal portion of exon 15 of
the APC gene are associated with a POFL-negative phenotype, while those
in exons 10 to the proximal portion of exon I5 are generally associated
with a POFL-positive
38
UI - 9229577
AU - Giardiello FM
TI -
NSAID-induced polyp regression in familial adenomatous polyposis
patients.
SO - Gastroenterol Clin North Am 1996 Jun;25(2):349-62
AD - Deparment of Medicine, Johns Hopkins University School of Medicine,
Baltimore, MD, USA.
NSAIDs inhibit prostaglandin synthesis. In 1983, Waddell et al first
reported that sulindac, a NSAID (Clinoril), caused regression of rectal
adenomatous polyps in several patients with familial adenomatous
polyposis, an inherited form of colorectal cancer. Subsequently, NSAIDs
have been used as chemopreventive agents in animal carcinogenesis models
and adenoma regression had been confirmed in human trials with sulindac.
This article summarizes these developments and describes possible
mechanisms of colorectal neoplasia chemoprevention.
39
UI - 9152835
AU - DudokdeWit AC; Tibben A; Duivenvoorden HJ; Frets PG; Zoeteweij MW;
TI -
Losekoot M; van Haeringen A; Niermeijer MF; Passchier J
Psychological distress in applicants for predictive DNA testing for
autosomal dominant, heritable, late onset disorders. The
Rotterdam/Leiden Genetics Workgroup.
SO - J Med Genet 1997 May;34(5):382-90
AD - Department of Medical Psychology, Erasmus University Rotterdam, The
Netherlands.
In a comparative study on the effects of predictive DNA testing for late
onset disorders, pre-test psychological distress was assessed in people
at risk for Huntington's disease (HD, n = 41), cerebral haemorrhage
(HCHWA-D, n = 9), breast and ovarian cancer (HBOC, n = 24), and
polyposis coli (FAP, n = 45). Partners, if available, also participated
in the study. Distress was measured with the subscales Intrusion and
Avoidance of the Impact of Event Scale. People at risk for the
neurodegenerative disorders reported more avoidance than those at risk
for the cancer syndromes. People at risk for FAP and partners of those
at risk for HBOC reported less intrusion than the others at risk and the
other partners. Subjects who were more distressed reported more
experiences with the disease in close relatives, the disease having a
great impact on their lives, having considerations against predictive
testing, expecting that being identified as a gene carrier would have
adverse effects, and expecting relief after being identified
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
